Filter News
Area of Research
- (-) Neutron Science (7)
- (-) Nuclear Science and Technology (2)
- Biology and Environment (7)
- Clean Energy (6)
- Computational Biology (1)
- Computational Engineering (1)
- Fusion and Fission (1)
- Isotopes (3)
- Materials (5)
- Materials for Computing (3)
- National Security (6)
- Sensors and Controls (1)
- Supercomputing (12)
News Topics
- (-) Biomedical (8)
- (-) Security (1)
- 3-D Printing/Advanced Manufacturing (5)
- Advanced Reactors (6)
- Artificial Intelligence (2)
- Big Data (1)
- Bioenergy (5)
- Biology (4)
- Biotechnology (1)
- Chemical Sciences (1)
- Climate Change (1)
- Composites (1)
- Computer Science (7)
- Coronavirus (5)
- Cybersecurity (1)
- Decarbonization (2)
- Energy Storage (4)
- Environment (4)
- Frontier (1)
- Fusion (3)
- High-Performance Computing (1)
- Isotopes (3)
- Materials (9)
- Materials Science (17)
- Microscopy (2)
- Molten Salt (3)
- Nanotechnology (7)
- National Security (1)
- Neutron Science (64)
- Nuclear Energy (18)
- Physics (8)
- Quantum Science (5)
- Space Exploration (6)
- Summit (4)
- Sustainable Energy (3)
- Transformational Challenge Reactor (1)
- Transportation (3)
Media Contacts
More than 50 current employees and recent retirees from ORNL received Department of Energy Secretary’s Honor Awards from Secretary Jennifer Granholm in January as part of project teams spanning the national laboratory system. The annual awards recognized 21 teams and three individuals for service and contributions to DOE’s mission and to the benefit of the nation.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
As the rise of antibiotic-resistant bacteria known as superbugs threatens public health, Oak Ridge National Laboratory’s Shuo Qian and Veerendra Sharma from the Bhaba Atomic Research Centre in India are using neutron scattering to study how an antibacterial peptide interacts with and fights harmful bacteria.
A team of scientists, led by University of Guelph professor John Dutcher, are using neutrons at ORNL’s Spallation Neutron Source to unlock the secrets of natural nanoparticles that could be used to improve medicines.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.